Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal insulin for motor and non-motor symptoms in Parkinson's disease
IRCT20191022045196N1Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jan 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Parkinson's disease (PD) comparing Intranasal insulin with Placebo (2 arms). Primary endpoints: Motor symptom change and Non-motor symptom change. Started Jan 2020; status: completed.
02
Drugs
human insulin
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on IRCT20191022045196N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191022045196N1.